COO
Price
$64.58
Change
-$9.53 (-12.86%)
Updated
Aug 28 closing price
Capitalization
12.88B
97 days until earnings call
SYK
Price
$389.67
Change
-$3.48 (-0.89%)
Updated
Aug 28 closing price
Capitalization
148.97B
62 days until earnings call
Interact to see
Advertisement

COO vs SYK

Header iconCOO vs SYK Comparison
Open Charts COO vs SYKBanner chart's image
Cooper Companies (The)
Price$64.58
Change-$9.53 (-12.86%)
Volume$14.91M
Capitalization12.88B
Stryker
Price$389.67
Change-$3.48 (-0.89%)
Volume$1.03M
Capitalization148.97B
COO vs SYK Comparison Chart in %
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. SYK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and SYK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (COO: $64.58 vs. SYK: $389.67)
Brand notoriety: COO and SYK are both not notable
COO represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: COO: 584% vs. SYK: 68%
Market capitalization -- COO: $12.88B vs. SYK: $148.97B
COO [@Pharmaceuticals: Other] is valued at $12.88B. SYK’s [@Medical/Nursing Services] market capitalization is $148.97B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.86B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $228.64B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileSYK’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • SYK’s FA Score: 1 green, 4 red.
According to our system of comparison, SYK is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 6 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 6 bearish.
  • SYK’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYK is a better buy in the short-term than COO.

Price Growth

COO (@Pharmaceuticals: Other) experienced а -11.58% price change this week, while SYK (@Medical/Nursing Services) price change was +1.26% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.91%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +15.22%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.89%. For the same industry, the average monthly price growth was +5.50%, and the average quarterly price growth was +9.92%.

Reported Earning Dates

COO is expected to report earnings on Dec 04, 2025.

SYK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.91% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($149B) has a higher market cap than COO($12.9B). SYK has higher P/E ratio than COO: SYK (51.61) vs COO (31.66). SYK YTD gains are higher at: 8.709 vs. COO (-29.751). SYK has higher annual earnings (EBITDA): 5.76B vs. COO (1.1B). SYK has more cash in the bank: 2.46B vs. COO (116M). COO has less debt than SYK: COO (2.59B) vs SYK (16.6B). SYK has higher revenues than COO: SYK (23.8B) vs COO (3.99B).
COOSYKCOO / SYK
Capitalization12.9B149B9%
EBITDA1.1B5.76B19%
Gain YTD-29.7518.709-342%
P/E Ratio31.6651.6161%
Revenue3.99B23.8B17%
Total Cash116M2.46B5%
Total Debt2.59B16.6B16%
FUNDAMENTALS RATINGS
COO vs SYK: Fundamental Ratings
COO
SYK
OUTLOOK RATING
1..100
6163
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10016
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6355
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (70) in the Medical Specialties industry is in the same range as COO (76). This means that SYK’s stock grew similarly to COO’s over the last 12 months.

SYK's Profit vs Risk Rating (16) in the Medical Specialties industry is significantly better than the same rating for COO (100). This means that SYK’s stock grew significantly faster than COO’s over the last 12 months.

SYK's SMR Rating (100) in the Medical Specialties industry is in the same range as COO (100). This means that SYK’s stock grew similarly to COO’s over the last 12 months.

SYK's Price Growth Rating (55) in the Medical Specialties industry is in the same range as COO (63). This means that SYK’s stock grew similarly to COO’s over the last 12 months.

SYK's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as COO (100). This means that SYK’s stock grew similarly to COO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COOSYK
RSI
ODDS (%)
Bullish Trend 1 day ago
61%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
48%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
61%
MACD
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bullish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 3 days ago
60%
Bullish Trend 10 days ago
56%
Declines
ODDS (%)
Bearish Trend 9 days ago
59%
Bearish Trend 1 day ago
51%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
51%
Bearish Trend 1 day ago
60%
Aroon
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DWAS90.260.34
+0.38%
Invesco Dorsey Wright SmallCap Momt ETF
BSMU21.650.01
+0.02%
Invesco BulletShares 2030 Muncpl Bd ETF
STIP103.84N/A
N/A
iShares 0-5 Year TIPS Bond ETF
MCDS57.75N/A
N/A
JPMorgan Fundamental Data Sci Md Cor ETF
THTA15.01-0.01
-0.06%
SoFi Enhanced Yield ETF

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
-12.85%
A - COO
50%
Loosely correlated
+5.28%
ALC - COO
48%
Loosely correlated
-2.36%
RGEN - COO
47%
Loosely correlated
+2.77%
DHR - COO
46%
Loosely correlated
+0.14%
SYK - COO
44%
Loosely correlated
-0.89%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been loosely correlated with BSX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-0.89%
BSX - SYK
66%
Loosely correlated
-0.11%
ISRG - SYK
65%
Loosely correlated
+0.57%
A - SYK
56%
Loosely correlated
+5.28%
STE - SYK
55%
Loosely correlated
-1.69%
MDT - SYK
54%
Loosely correlated
-0.10%
More